Key clinical message
====================

Clinicians must be cognizant that patients with atypical chest pain infected with HIV may have silent critical left main coronary artery disease (CAD) despite being stratified as low risk after exercise stress test.

Introduction
============

CAD is currently one of the leading causes of mortality in patients with HIV. This is primarily attributed to their comparably increased life expectancy, antiretroviral induced metabolic derangements, and the lentivirus itself.[@b1-imcrj-11-139],[@b2-imcrj-11-139] The pathophysiology involves a complex milieu combining direct endothelial injury and dysfunction and hypercoagulability along with a significant contribution from traditional cardiac risk factors.[@b3-imcrj-11-139]--[@b5-imcrj-11-139]

Severe left main disease (LMD) occurs in \~3%--7% of overall patients undergoing index coronary angiography, and if treated with conservative medical management, a 3-year mortality rate of 50% was found.[@b6-imcrj-11-139],[@b7-imcrj-11-139] In the HIV-infected subpopulation, the prevalence is \~6% as demonstrated in the studies by Escaut et al[@b8-imcrj-11-139] and Mehta and Khan[@b9-imcrj-11-139].

Accruing epidemiologic data on asymptomatic LMD with silent myocardial ischemia is difficult; however, sudden cardiac death and autopsy studies suggest that this entity is relatively common.[@b10-imcrj-11-139]

We describe a case report of silent critical LMD in an HIV-infected patient who was stratified as low risk according to the Duke treadmill score (DTS) of 12 after exercise stress test.

Case report
===========

Recently, a 56-year-old Caucasian gentleman with a medical history of HIV infection for 10 years, undergoing antiretroviral therapy (ART) including efavirenz, emtricitabine, and tenofovir, initially presented to the outpatient cardiology clinic for atypical, noncardiac chest pain. His physical examination and vital signs were unremarkable. A 12-lead electrocardiogram (ECG) revealed sinus rhythm with no acute ischemic changes. Recent pertinent laboratory investigations included the following: a normal complete blood count, comprehensive metabolic panel, lipid panel, inflammatory markers such as erythrocyte sedimentation rate and C-reactive protein, glycosylated hemoglobin (HbA~1c~), cluster of differentiation 4 (CD4) count of 860 cells/mm^3^ (normal range, 500--1,500 cells/mm^3^), and undetectable HIV RNA levels (\<20 RNA copies/µL). His cardiac troponin T was normal at 0.028 ng×mL^−1^ (normal range, 0--0.1 ng×mL^−1^) and did not reflect a myocardial infarction. He was subsequently risk stratified according to Bruce protocol exercise treadmill test, during which he did not report any anginal episodes and achieved 12 minutes and 23 seconds of exercise time with 13.2 metabolic equivalents (METs) and no significant ST-segment deviation. His DTS was calculated at 12, which is considered a low risk for cardiovascular events ([Figure 1A--C](#f1-imcrj-11-139){ref-type="fig"}).[@b11-imcrj-11-139]

The patient returned the following fortnight due to persistent atypical chest pain, and as a result, he was hospitalized for further management. Once again, ECGs and cardiac biomarkers of the patient were unremarkable. He was then proceeded to inpatient coronary angiography. Cardiac catheterization revealed an eccentric, critical mid-left main lesion with 90% stenosis (American College of Cardiology/American Heart Association \[ACC/AHA\] type C) with a diffuse, proximal left anterior descending artery (LAD) stenosis ([Figure 2A--C](#f2-imcrj-11-139){ref-type="fig"}). The left main lesion was unable to be further characterized with intravascular ultrasound or optical coherence tomography due to the unavailability of these imaging modalities. He remained hospitalized and subsequently underwent successful double coronary artery bypass grafting (CABG) the following day without complications. The patient was then safely discharged following his uneventful postoperative recovery on guideline-directed medical therapy which included aspirin 81 mg, clopidogrel 75 mg, lisinopril 2.5 mg, carvedilol 3.125 mg twice daily, spironolactone 12.5 mg, and pravastatin 20 mg in addition to his maintenance ART.

All procedures performed in studies involving human participants were in accordance with the ethical standards of the institutional and/or national research committee and the 1964 Declaration of Helsinki and its later amendments or comparable ethical standards. The patient has provided written informed consent to have the details of his case published.

Discussion
==========

Although the patient reported atypical chest pain, his symptoms were not considered to be related to the discovery of his severe left main coronary artery (LMCA) lesion, and thus, were initially considered noncardiac in nature. The mechanisms for the atypical presentation with a high DTS (\>12) despite having severe LMD remain unclear. Possible reasons include ART-induced neuropathy which may have masked definitive typical angina or its equivalent along with an HIV-associated neuropathy despite the patient being well controlled as evidenced by his CD4 count and undetectable viral load. There was also no significant coronary collateral circulation present which could attenuate any classical symptoms.[@b12-imcrj-11-139] To the authors' knowledge, this is the reported first-in-human case of illustrating the phenomenon of an oligosymptomatic left main lesion in an HIV-infected patient who underwent a low-risk exercise treadmill test.

Generally, HIV-infected patients have a significantly higher risk of developing acute coronary syndromes (ACSs).[@b13-imcrj-11-139] This is in part due to a thrombophilic phenomenon which is attributed to various cellular and plasmatic factors, including decreased levels of natural anticoagulants, increased levels of plasminogen activator inhibitor-1, activated protein C resistance, and platelet reactivity.[@b14-imcrj-11-139] The patient proceeded to angiography based on the discordance between the atypical symptoms and a low-risk exercise stress test (DTS\>12) despite the growing evidence that achieving ≥10 METs with a negative stress ECG resulted in 94% sensitivity and 97% negative predictive value in identifying high-risk CAD.[@b15-imcrj-11-139]

The prevalence of significant LMD appears to be 6%, which is equivalent to a non-HIV-infected cohort.[@b8-imcrj-11-139],[@b9-imcrj-11-139] Coronary anatomy seems to be variable, with some studies showing a higher prevalence of single-vessel disease and others multi-vessel disease.[@b16-imcrj-11-139]

CABG has long been considered as the gold standard treatment of unprotected LMCA disease. Currently, there is a dearth of studies with respect to surgical revascularization in HIV-infected patients.[@b17-imcrj-11-139],[@b18-imcrj-11-139] These surmised that both short- and long-term outcomes are similar to their noninfected counterparts with respect to cardiovascular mortality and prognosis.

With the advent of drug-eluting stents (DESs), together with advances in adjunctive pharmacotherapies, percutaneous coronary intervention (PCI) is also a feasible revascularization strategy for patients with unprotected LMCA stenosis.[@b19-imcrj-11-139],[@b20-imcrj-11-139] PCI in HIV-infected patients has been associated with a higher incidence of nonfatal reinfarction, restenosis, and in-stent thrombosis requiring repeat revascularization.[@b16-imcrj-11-139],[@b21-imcrj-11-139],[@b22-imcrj-11-139] It has also been demonstrated that DESs display equivalent safety and efficacy in the HIV-infected population as in the general population.[@b23-imcrj-11-139]--[@b25-imcrj-11-139]

Conclusion
==========

We describe a case report of an atypical presentation of silent critical LMD in an HIV-infected patient who underwent a low-risk exercise stress test. The cardiovascular disease team should be vigilant for this latent phenomenon, specifically within this subpopulation despite the high DTS and markedly above normal functional capacity. Although CABG remains the gold standard of care for the management of LMD, drug-eluting PCI remains a viable option with streamlined procedural techniques, cutting edge devices, and novel adjunctive pharmacology.
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![Exercise stress ECGs.\
**Notes:** (**A**) The patient's baseline ECG. (**B**) The patient's ECG at peak stress (Bruce protocol) with no acute dynamic changes consistent with ischemia or infarction. (**C**) The patient's ECG during recovery after exercise treadmill stress test with no ischemic changes.\
**Abbreviation:** ECG, electrocardiogram.](imcrj-11-139Fig1){#f1-imcrj-11-139}

![Left coronary artery angiography.\
**Notes:** (**A**) The white arrow indicates the mid-LMCA 90% stenosis. (**B**) The white arrow indicates the mid-LMCA 90% stenosis. (**C**) The white arrow indicates the mid-LMCA 90% stenosis and the black arrow indicates the proximal, diffuse left anterior descending artery 50% stenosis.\
**Abbreviation:** LMCA, left main coronary artery.](imcrj-11-139Fig2){#f2-imcrj-11-139}
